Does reduced cortisol signaling lower neutrophil mobilization and shift white blood cell proportions?

Physiological levels of cortisol are primary regulators of immune cell trafficking, actively driving the mobilization of neutrophils and the redistribution of mononuclear cells. When cortisol signaling is reduced—such as in primary adrenal insufficiency or during glucocorticoid withdrawal—these regulatory pathways are disrupted, resulting in distinct hematologic alterations.

Mechanistic pathways of reduced mobilization

• Neutrophil retention: Cortisol normally facilitates bone marrow egress by downregulating the CXCR4/CXCL12 retention axis and lowers endothelial adhesiveness by reducing L-selectin (CD62L) and beta-2 integrin (CD11/CD18) expression. Decreased cortisol signaling prevents these changes, leading to increased bone marrow retention, enhanced vascular marginated adherence, and a subsequent drop in circulating neutrophil mobilization.
• Mononuclear accumulation: Normal cortisol levels promote lymphocyte apoptosis and stimulate homing receptors that direct lymphocytes out of the blood and into lymphoid tissues. The loss of this signal stops this active clearance and redistribution, allowing lymphocytes and monocytes to accumulate and persist in the bloodstream.

Clinical implications and hematologic profile

• Leukocyte distribution shift: The combination of lower neutrophil egress and decreased lymphocyte clearance alters the relative white blood cell differential. This frequently manifests clinically as relative neutropenia paired with relative lymphocytosis (often pushing the lymphocyte differential to 50% or higher) and relative monocytosis.

Bottom line

• Decreased cortisol signaling directly impairs neutrophil demargination and bone marrow egress while preserving circulating lymphocytes and monocytes, resulting in a characteristic shift toward relative lymphocyte and monocyte predominance in peripheral blood.